KSF News & Victories
In a complaint filed on August 14, 2026 on behalf of Medical Properties Trust, plaintiff alleges, among other things, that certain of the company’s officers and directors breached their fiduciary duties, abused their control, grossly mismanaged the company, wasted corporate assets, and were unjustly enriched.
On August 12, 2026, the Delaware Court of Chancery denied defendants’ motion to dismiss a merger class action where KSF is acting as sole lead counsel.
On August 11, 2026, the United States District Court for the District of Minnesota largely denied defendants’ motion to dismiss the amended complaint in an ERISA class action.
In a complaint filed on July 10, 2026 against Rivian Automotive, plaintiff alleges that defendants breached their fiduciary duties, engaged in insider trading, and unjustly enriched themselves.
On July 8, 2026, the United States District Court for the Southern District of New York denied defendants’ motion to dismiss in a securities class action where KSF is acting as Co-Lead Counsel.
Plaintiffs allege that Gemini and certain of its executives have violated federal securities laws by making misrepresentations and omissions regarding their intention to prioritize a prediction markets business instead of their existing cryptocurrency platform.
In a complaint filed on May 22, 2026, plaintiffs allege that Aon and certain of its officers and directors breached their fiduciary duties and seek over $120 million in alleged damages.
In an order entered on May 21, 2026, the Delaware Court of Chancery stayed a shareholder derivative action brought by KSF on behalf of Acadia Healthcare in light of the parties’ agreement in principle to settle the claims asserted therein and in certain related derivative actions.
In a status report filed on May 19, 2026, the parties to a shareholder derivative action brought on behalf of Acadia Pharmaceuticals in California federal court advised that they had substantially completed documenting a settlement of the claims asserted therein and in certain related stockholder demands, including a stockholder demand served by KSF.
Ms. Nicholson served on the Securities Litigation faculty for the sixth consecutive year at PLI’s continuing legal education program Securities Litigation 2026: From Investigation to Trial, held in New York City on April 27, 2026.
KSF filed an ERISA class action complaint on April 17, 2026, against Providence Health & Services, St. Joseph Health System, and certain of their officers and directors alleging that defendants breached their fiduciary duties.
Vice Chancellor Nathan A. Cook denied the defendants’ motion to dismiss KSF’s class action complaint in its entirety. KSF’s complaint, filed in the Delaware Court of Chancery on behalf of former stockholders of Trecora Resources Inc., alleges that Trecora’s directors breached their duty of loyalty in connection with the sale of Trecora.
On March 25, 2026, the Hon. Michelle Williams Court, United States District Judge for the Central District of California, denied in full Defendants National Collegiate Athletic Association and Turner Sports Interactive’s motion to dismiss a data privacy class action complaint.
Plaintiffs allege that defendants breached their fiduciary duties by, among other things, failing to divest underperforming investments, engaging in transactions prohibited by ERISA.
Plaintiffs allege that defendants breached their fiduciary duties by, among other things, failing to divest underperforming investments, engaging in transactions prohibited by ERISA.
In a complaint filed on January 28, 2026, plaintiffs allege that Dell and certain of its officers and directors breached their fiduciary duties and seek over $318 million in alleged damages.
On October 22, 2025, the Hon. Jesus G. Bernal denied CoStar defendant’s motion to dismiss a data privacy class action complaint. The suit alleges that CoStar installed trackers on its websites that collected and shared users’ personal information.
James Fetter, an associate at KSF who is blind, participated in a panel discussion hosted by the ABA Commission on Disability Rights about navigating the legal profession with a disability.
After more than four years of litigation, the Hon. Maxine Chesney entered a Final Judgment approving a $27.5 million settlement for the Class in a Class action against Aimmune Therapeutics.
On July 7, 2025, the court certified a class of shareholders and noteholders in In re: Credit Suisse Securities Fraud Class Actions (Diabat), No. 1:23-cv-05874-CM (S.D.N.Y.), a securities fraud class action pending in the United States District Court for the Southern District of New York.